Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900026098Phase 4Not yet recruiting
Phase 4, open-label trial of remifentanil and sevoflurane in pneumonia (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: PACU residence time. Planned start Oct 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900026098.